Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Apr;75(4):349–351. doi: 10.1136/hrt.75.4.349

Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide.

T P Dormans 1, R M Huige 1, P G Gerlag 1
PMCID: PMC484308  PMID: 8705759

Abstract

OBJECTIVE: To assess the benefits and problems of chronic intermittent treatment with haemofiltration or haemodialysis or both in patients with severe chronic heart failure (New York Heart Association class III or IV) and oedema refractory to pharmacological treatment. DESIGN AND SETTING: A retrospective case-cohort study. A general hospital in The Netherlands. PATIENTS: The results of chronic intermittent treatment with haemofiltration (n = 10) or haemodialysis (n = 2) were analysed in patients with severe chronic heart failure, predominantly due to coronary heart disease, and oedema refractory to a pharmacological regimen including high dose frusemide. INTERVENTION: Patients had an average of 25 (SD 38) treatments. RESULTS: There was improvement of NYHA class IV to III in seven patients. However, this was not reflected in a decrease in hospital admission: only two patients could be managed as outpatients. The median survival after start of the treatment was 24 days (varying from 0 to 393 days). In four patients the treatment was discontinued after discussion with the patient and family. CONCLUSIONS: The use of chronic intermittent haemofiltration and haemodialysis is of limited value in end stage chronic heart failure with oedema, refractory to maximal conventional treatment.

Full text

PDF
349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biasioli S., Barbaresi F., Barbiero M., Petrosino L., Cavallini L., Zambello A., Cavalcanti G., Foroni R., Bonofiglio C. Intermittent venovenous hemofiltration as a chronic treatment for refractory and intractable heart failure. ASAIO J. 1992 Jul-Sep;38(3):M658–M663. doi: 10.1097/00002480-199207000-00119. [DOI] [PubMed] [Google Scholar]
  2. Fauchald P., Forfang K., Amlie J. An evaluation of ultrafiltration as treatment of therapy-resistant cardiac edema. Acta Med Scand. 1986;219(1):47–52. doi: 10.1111/j.0954-6820.1986.tb03274.x. [DOI] [PubMed] [Google Scholar]
  3. Gerlag P. G., van Meijel J. J. High-dose furosemide in the treatment of refractory congestive heart failure. Arch Intern Med. 1988 Feb;148(2):286–291. [PubMed] [Google Scholar]
  4. König P., Geissler D., Lechleitner P., Spielberger M., Dittrich P. Improved management of congestive heart failure. Use of continuous ambulatory peritoneal dialysis. Arch Intern Med. 1987 Jun;147(6):1031–1034. doi: 10.1001/archinte.1987.00370060027005. [DOI] [PubMed] [Google Scholar]
  5. McKinnie J. J., Bourgeois R. J., Husserl F. E. Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis. Arch Intern Med. 1985 Jun;145(6):1128–1129. [PubMed] [Google Scholar]
  6. Morgan S. H., Mansell M. A., Thompson F. D. Fluid removal by haemofiltration in diuretic resistant cardiac failure. Br Heart J. 1985 Aug;54(2):218–219. doi: 10.1136/hrt.54.2.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Rimondini A., Cipolla C. M., Della Bella P., Grazi S., Sisillo E., Susini G., Guazzi M. D. Hemofiltration as short-term treatment for refractory congestive heart failure. Am J Med. 1987 Jul;83(1):43–48. doi: 10.1016/0002-9343(87)90495-5. [DOI] [PubMed] [Google Scholar]
  8. Rodeheffer R. J., Jacobsen S. J., Gersh B. J., Kottke T. E., McCann H. A., Bailey K. R., Ballard D. J. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc. 1993 Dec;68(12):1143–1150. doi: 10.1016/s0025-6196(12)60063-9. [DOI] [PubMed] [Google Scholar]
  9. Rubin J., Ball R. Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases. Arch Intern Med. 1986 Aug;146(8):1533–1535. [PubMed] [Google Scholar]
  10. Shilo S., Slotki I. N., Iaina A. Improved renal function following acute peritoneal dialysis in patients with intractable congestive heart failure. Isr J Med Sci. 1987 Jul;23(7):821–824. [PubMed] [Google Scholar]
  11. Silverstein M. E., Ford C. A., Lysaght M. J., Henderson L. W. Treatment of severe fluid overload by ultrafiltration. N Engl J Med. 1974 Oct 10;291(15):747–751. doi: 10.1056/NEJM197410102911501. [DOI] [PubMed] [Google Scholar]
  12. Simpson I. A., Rae A. P., Simpson K., Gribben J., Boulton Jones J. M., Allison M. E., Hutton I. Ultrafiltration in the management of refractory congestive heart failure. Br Heart J. 1986 Apr;55(4):344–347. doi: 10.1136/hrt.55.4.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Van Meyel J. J., Gerlag P. G., Smits P., Russel F. G., Tan Y., Van Ginneken C. A., Gribnau F. W. Absorption of high dose furosemide (frusemide) in congestive heart failure. Clin Pharmacokinet. 1992 Apr;22(4):308–318. doi: 10.2165/00003088-199222040-00006. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES